Paper Details

  1. Home
  2. Paper Details

Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia.

Author: AstileanSimion, Berindan-NeagoeIoana, BocaSanda, BojanAnca, SimonTimea, TomuleasaCiprian

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Nano-carriers of drugs can accumulate and release their payload specifically at the tumor site, increasing the clinical outcome of anti-tumor treatments and reducing systemic damage and side effects.
Paper Details　
Original Abstract of the Article :
Releasing drug molecules at the targeted location could increase the clinical outcome of a large number of anti-tumor treatments which require low systemic damage and low side effects. Nano-carriers of drugs show great potential for such task due to their capability of accumulating and releasing the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666845/

データ提供：米国国立医学図書館（NLM）

FLT3 Inhibitor-Gold Nanoparticle Conjugates: A New Oasis in the Desert of Leukemia

The fight against [acute myeloid leukemia (AML)] is like traversing a vast desert, seeking a cure for this deadly disease. This research explores a new approach to combatting AML by targeting the tumor site with [FLT3 inhibitor-gold nanoparticle conjugates]. These nano-carriers, like oases in a desert, deliver potent drugs directly to the tumor, minimizing damage to healthy cells. The researchers aim to unlock the potential of this innovative technology to improve patient outcomes.

A Targeted Approach to AML

The study demonstrates the potential of nano-carriers for targeted drug delivery. This innovative approach could revolutionize the treatment of AML, reducing side effects and improving therapeutic efficacy.

Hope for AML Patients on the Horizon

The development of FLT3 inhibitor-gold nanoparticle conjugates represents a significant advance in the fight against AML. This promising new therapy offers hope for individuals battling this disease, providing a glimmer of light in a challenging landscape.

Dr. Camel's Conclusion

This research serves as a reminder that innovation is the key to unlocking new treatments for complex diseases like AML. The use of nano-carriers to deliver drugs directly to the tumor represents a promising approach that could bring new hope to patients.

Date :
  1. Date Completed 2015-12-15
  2. Date Revised 2020-09-29
Further Info :

Pubmed ID

26625890

DOI: Digital Object Identifier

PMC4666845

Related Literature

Article Analysis
・Side Effects of quizartinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.